EGFR and non-small cell lung carcinoma: TCM has gained significant popularity as an alternative and supplementary treatment for advanced NSCLC (Jiao et al., 2019), potentially mitigating the adverse effects of EGFR-TKIs (Hu et al., 2021) and improving QOL.